The U.S. Section of Well being and Human Products and services introduced Tuesday that it would invest $1.6 billion towards the commercial enhancement of a COVID-19 investigational vaccine by the Maryland-based mostly company Novavax.
HHS also introduced that it would deliver $450 million to Regeneron to manufacture and supply the company’s antiviral antibody cure, REGN-COV2.
The medical trials for both equally the vaccine and the cure are continue to underway.
The funding assignments have been carried out as a joint energy amongst HHS and